Tributary Capital Management Reduces Stake in CareTrust REIT

The institutional investor sold over 100,000 shares of the healthcare real estate investment trust in Q4 2025.

Apr. 19, 2026 at 12:26pm

Got story updates? Submit your updates here. ›

An extreme close-up of intricate, industrial-looking financial machinery and equipment, conveying the complex institutional forces behind healthcare real estate investments.A reduction in institutional ownership of CareTrust REIT shares may signal shifting market sentiment around the healthcare real estate investment trust.Deerfield Beach Today

Tributary Capital Management LLC, an institutional investor, reduced its stake in CareTrust REIT, Inc. (NYSE: CTRE) by 27.6% during the fourth quarter of 2025. The firm sold 104,790 shares, leaving it with a remaining position of 274,647 shares worth $9.93 million.

Why it matters

CareTrust REIT is a prominent healthcare-focused real estate investment trust that owns and manages skilled nursing, assisted living, and other post-acute care facilities across the United States. Changes in institutional ownership can signal shifts in market sentiment around the company's performance and future prospects.

The details

According to a regulatory filing, Tributary Capital Management sold 104,790 shares of CareTrust REIT during the fourth quarter of 2025, reducing its total position to 274,647 shares. The firm previously owned about 0.12% of CareTrust's outstanding stock.

  • Tributary Capital Management reduced its CareTrust REIT stake in Q4 2025.

The players

Tributary Capital Management LLC

An institutional investment firm that reduced its position in CareTrust REIT by over 27% in the fourth quarter of 2025.

CareTrust REIT, Inc.

A real estate investment trust that owns and manages healthcare properties, including skilled nursing, assisted living, and post-acute care facilities across the United States.

Got photos? Submit your photos here. ›

The takeaway

The reduction in Tributary Capital Management's stake in CareTrust REIT could signal a shift in market sentiment around the healthcare REIT's performance and future prospects, though the reasons behind the sale are not entirely clear from the limited information provided.